94 related articles for article (PubMed ID: 23859481)
21. Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08.
Lones MA; Heerema NA; Le Beau MM; Perkins SL; Kadin ME; Kjeldsberg CR; Sposto R; Meadows A; Siegel S; Buckley J; Finlay J; Abromowitch M; Cairo MS; Sanger WG
Cancer Genet Cytogenet; 2006 Dec; 171(2):89-96. PubMed ID: 17116485
[TBL] [Abstract][Full Text] [Related]
22. Specific patterns of chromosomal gains and losses associate with t(3;14), t(8;14), and t(14;18) in diffuse large B-cell lymphoma.
Sheth A; de Melo VA; Szydlo R; Macdonald DH; Reid AG; Wagner SD
Cancer Genet Cytogenet; 2009 Oct; 194(1):48-52. PubMed ID: 19737654
[TBL] [Abstract][Full Text] [Related]
23. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
Tzankov A; Gschwendtner A; Augustin F; Fiegl M; Obermann EC; Dirnhofer S; Went P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2125-32. PubMed ID: 16609025
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization.
Berglund M; Enblad G; Flordal E; Lui WO; Backlin C; Thunberg U; Sundström C; Roos G; Allander SV; Erlanson M; Rosenquist R; Larsson C; Lagercrantz S
Mod Pathol; 2002 Aug; 15(8):807-16. PubMed ID: 12181265
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.
Niitsu N; Okamoto M; Nakamura N; Nakamine H; Aoki S; Hirano M; Miura I
Leuk Res; 2007 Sep; 31(9):1191-7. PubMed ID: 17197022
[TBL] [Abstract][Full Text] [Related]
26. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome).
Beà S; López-Guillermo A; Ribas M; Puig X; Pinyol M; Carrió A; Zamora L; Soler F; Bosch F; Stilgenbauer S; Colomer D; Miró R; Montserrat E; Campo E
Am J Pathol; 2002 Sep; 161(3):957-68. PubMed ID: 12213724
[TBL] [Abstract][Full Text] [Related]
27. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
28. Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.
Nakamura N; Goto N; Tsurumi H; Takemura M; Kanemura N; Kasahara S; Hara T; Yasuda I; Shimizu M; Sawada M; Yamada T; Seishima M; Takami T; Moriwaki H
Eur J Haematol; 2013 Oct; 91(4):322-31. PubMed ID: 23672298
[TBL] [Abstract][Full Text] [Related]
29. High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas.
Salaverria I; Martin-Guerrero I; Burkhardt B; Kreuz M; Zenz T; Oschlies I; Arnold N; Baudis M; Bens S; García-Orad A; Lisfeld J; Schwaenen C; Szczepanowski M; Wessendorf S; Pfreundschuh M; Trümper L; Klapper W; Siebert R
Genes Chromosomes Cancer; 2013 Feb; 52(2):150-5. PubMed ID: 23073988
[TBL] [Abstract][Full Text] [Related]
30. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
[TBL] [Abstract][Full Text] [Related]
31. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.
Jerkeman M; Anderson H; Dictor M; Kvaløy S; Akerman M; Cavallin-Ståhl E;
Ann Hematol; 2004 Jul; 83(7):414-9. PubMed ID: 15085385
[TBL] [Abstract][Full Text] [Related]
32. Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
Simonitsch-Klupp I; Hauser I; Ott G; Drach J; Ackermann J; Kaufmann J; Weltermann A; Greinix HT; Skrabs C; Dittrich C; Lutz D; Pötter R; Mannhalter C; Lechner K; Chott A; Jaeger U
Leukemia; 2004 Jan; 18(1):146-55. PubMed ID: 14603341
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic value of P53 aberrations in diffuse large B-cell lymphoma].
Lu JT; Cen L; Zhou M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):100-2. PubMed ID: 22391175
[TBL] [Abstract][Full Text] [Related]
34. Numerical chromosomal abnormality in gastric MALT lymphoma and diffuse large B-cell lymphoma.
Watanobe I; Takamori S; Kojima K; Fukasawa M; Beppu T; Futagawa S; Hirai S
J Gastroenterol; 2002; 37(9):691-6. PubMed ID: 12375141
[TBL] [Abstract][Full Text] [Related]
35. Topo IIα gene alterations correlated with survival in patients with diffuse large B-cell lymphoma.
Chen Z; Wang J; Zhang H; Liu D; Li Y; Xu Y; Tan D; Chen D; Zhao X; Wang G
Eur J Clin Invest; 2012 Mar; 42(3):310-20. PubMed ID: 21880040
[TBL] [Abstract][Full Text] [Related]
36. [THE PROGNOSTIC IMPACT OF CHROMOSOMAL ABERRATIONS IN TUMOR TISSUE BIOPSIES FROM PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA].
Fahoum I; Ziv M; Bar-El H; Attias D; Tadmor T
Harefuah; 2016 Jan; 155(1):45-9, 66. PubMed ID: 27012075
[TBL] [Abstract][Full Text] [Related]
37. Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Klapper W; Stoecklein H; Zeynalova S; Ott G; Kosari F; Rosenwald A; Loeffler M; Trümper L; Pfreundschuh M; Siebert R;
Leukemia; 2008 Dec; 22(12):2226-9. PubMed ID: 18754028
[TBL] [Abstract][Full Text] [Related]
38. Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome.
Larouche JF; Berger F; Chassagne-Clément C; Ffrench M; Callet-Bauchu E; Sebban C; Ghesquières H; Broussais-Guillaumot F; Salles G; Coiffier B
J Clin Oncol; 2010 Apr; 28(12):2094-100. PubMed ID: 20308668
[TBL] [Abstract][Full Text] [Related]
39. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
Yamaguchi M; Nakamura N; Suzuki R; Kagami Y; Okamoto M; Ichinohasama R; Yoshino T; Suzumiya J; Murase T; Miura I; Ohshima K; Nishikori M; Tamaru J; Taniwaki M; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
Haematologica; 2008 Aug; 93(8):1195-202. PubMed ID: 18556402
[TBL] [Abstract][Full Text] [Related]
40. Chromosomal imbalances: a hallmark of tumour relapse in primary cutaneous CD30+ T-cell lymphoma.
Prochazkova M; Chevret E; Beylot-Barry M; Sobotka J; Vergier B; Delaunay M; Turmo M; Ferrer J; Kuglik P; Merlio JP
J Pathol; 2003 Nov; 201(3):421-9. PubMed ID: 14595754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
